Vittia (VITT3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
30 Aug, 2026Executive summary
Net revenue grew 6.2% year-over-year in 3Q24 to R$309.4 million and 3.5% in 9M24 to R$530.8 million, despite a challenging agricultural environment marked by severe drought and market uncertainty.
Adjusted EBITDA declined 7.7% year-over-year in 3Q24 and 25.8% in 9M24, mainly due to lower gross profit, margin compression, and higher costs.
Net income dropped 21.0% in 3Q24 to R$45.8 million and 48.4% in 9M24 to R$28.9 million.
The company maintained financial solidity, with a net debt/EBITDA ratio of 0.93x and continued investments in R&D, capacity expansion, and innovation.
Share buybacks and dividend payments were executed, with a new program launched for up to 4.5 million shares.
Financial highlights
Net revenue: R$309.4 million in 3Q24 (+6.2% YoY), R$530.8 million in 9M24 (+3.5% YoY).
Adjusted EBITDA: R$83.2 million in 3Q24 (-7.7% YoY), R$71.9 million in 9M24 (-25.8% YoY).
Net income: R$45.8 million in 3Q24 (-21.0% YoY), R$28.9 million in 9M24 (-48.4% YoY).
Capex: R$9.1 million in 3Q24 (-19.3% YoY), R$26.6 million in 9M24 (-30.5% YoY).
Gross margin: 35.6% in 3Q24 (-5.9 p.p. YoY), 32.3% in 9M24 (-4.8 p.p. YoY).
Outlook and guidance
Management expects resumed growth in biological pesticides in 4Q24 and continued robust performance in foliar fertilizers and micronutrients.
The company remains committed to closing the year with growth in sales and EBITDA, despite ongoing market volatility.
Off-season crops are anticipated to perform positively, supported by improved corn prices and favorable climate conditions.
The company remains cautious about 2025, expecting continued challenges but with less severity than in 2023-2024.
Latest events from Vittia
- Revenue up 37.3% in Q2 2024, but losses persisted as biologicals and investments grew.VITT3
Q2 2024 - Revenue up 4.0% in 2024, net income down 22.6%, with strong biologicals and solid financials.VITT3
Q4 2024 - Revenue up 13.4% year-over-year, but net loss of R$2.0 million and higher net debt.VITT3
Q1 2025 - Revenue up 7% in 1H25, but net loss widened; strong cash flow and new launches support resilience.VITT3
Q2 2025 - Revenue up 5.8% in 9M25, with strong cash flow and innovation amid margin pressure.VITT3
Q3 2025 - Revenue up 4.2% to R$820M, EBITDA down 13.6%, with strong cash flow and shareholder returns.VITT3
Q4 2025 - Revenue and profitability declined, but net debt fell 19.9% and investment in innovation increased.VITT3
Q1 2026 - Net revenue up 15.1% in 2Q26, strong cash flow, new launches, but EBITDA remains negative.VITT3
Q2 2026